Search Results - "Ostrowsky, Julia T."

A Research and Development (R&D) roadmap for influenza vaccines: Looking toward the future by Moore, Kristine A., Ostrowsky, Julia T., Kraigsley, Alison M., Mehr, Angela J., Bresee, Joseph S., Friede, Martin H., Gellin, Bruce G., Golding, Josephine P., Hart, Peter J., Moen, Ann, Weller, Charlotte L., Osterholm, Michael T., Ampofo, William, Barclay, Wendy, Cavaleri, Marco, Cohen, Cheryl, Cowling, Benjamin, Cox, Rebecca, Gust, Ian, Innis, Bruce, Kang, Gagandeep, Katz, Jacqueline, Krammer, Florian, Pitisuttithum, Punnee, Post, Diane, Rudenko, Larisa, Siqueira, Marilda, Weir, Jerry

“…Improved influenza vaccines are urgently needed to reduce the burden of seasonal influenza and to ensure a rapid and effective public-health response to future…”
Get full text

Advancing influenza vaccines: A review of next-generation candidates and their potential for global health impact by Taaffe, Jessica, Ostrowsky, Julia T., Mott, Joshua, Goldin, Shoshanna, Friede, Martin, Gsell, Pierre, Chadwick, Christopher

“…Influenza vaccines are an essential tool for influenza prevention, control and preparedness. However, demand for them and their programmatic suitability…”
Get full text

Development and deployment of COVID-19 vaccines for those most vulnerable by Koff, Wayne C, Schenkelberg, Theodore, Williams, Tere, Baric, Ralph S, McDermott, Adrian, Cameron, Cheryl M, Cameron, Mark J, Friemann, Matthew B, Neumann, Gabriele, Kawaoka, Yoshihiro, Kelvin, Alyson A, Ross, Ted M, Schultz-Cherry, Stacey, Mastro, Timothy D, Priddy, Frances H, Moore, Kristine A, Ostrowsky, Julia T, Osterholm, Michael T, Goudsmit, Jaap

“…Development of safe and effective COVID-19 vaccines is a global priority and the best hope for ending the COVID-19 pandemic. Remarkably, in less than 1 year,…”
Get more information

A research and development (R&D) roadmap for broadly protective coronavirus vaccines: A pandemic preparedness strategy by Moore, Kristine A., Leighton, Tabitha, Ostrowsky, Julia T., Anderson, Cory J., Danila, Richard N., Ulrich, Angela K., Lackritz, Eve M., Mehr, Angela J., Baric, Ralph S., Baylor, Norman W., Gellin, Bruce G., Gordon, Jennifer L., Krammer, Florian, Perlman, Stanley, Rees, Helen V., Saville, Melanie, Weller, Charlotte L., Osterholm, Michael T.

“…Broadly protective coronavirus vaccines are an important tool for protecting against future SARS-CoV-2 variants and could play a critical role in mitigating…”
Get full text

Measures to prevent and treat Nipah virus disease: research priorities for 2024–29 by Moore, Kristine A, Mehr, Angela J, Ostrowsky, Julia T, Ulrich, Angela K, Moua, Nicolina M, Fay, Petra C, Hart, Peter J, Golding, Josephine P, Benassi, Virginia, Preziosi, Marie-Pierre, Broder, Christopher C, de Wit, Emmie, Formenty, Pierre B H, Freiberg, Alexander N, Gurley, Emily S, Halpin, Kim, Luby, Stephen P, Mazzola, Laura T, Montgomery, Joel M, Spiropoulou, Christina F, Mourya, Devendra T, Parveen, Shahana, Rahman, Mahmudur, Roth, Cathy, Wang, Lin-Fa, Osterholm, Michael T

“…Nipah virus causes highly lethal disease, with case-fatality rates ranging from 40% to 100% in recognised outbreaks. No treatments or licensed vaccines are…”
Get full text

Lassa fever research priorities: towards effective medical countermeasures by the end of the decade by Moore, Kristine A, Ostrowsky, Julia T, Mehr, Angela J, Johnson, Rebecca A, Ulrich, Angela K, Moua, Nicolina M, Fay, Petra C, Hart, Peter J, Golding, Josephine P, Benassi, Virginia, Preziosi, Marie-Pierre, Adetifa, Ifedayo M, Akpede, George O, Ampofo, William K, Asogun, Danny A, Barrett, Alan D T, Bausch, Daniel G, de Coster, Ilse, Emperador, Devy M, Feldmann, Heinz, Fichet-Calvet, Elisabeth, Formenty, Pierre B H, Garry, Robert F, Grant, Donald S, Günther, Stephan, Gupta, Swati B, Jaspard, Marie, Mazzola, Laura T, Okogbenin, Sylvanus A, Roth, Cathy, Schmaljohn, Connie S, Osterholm, Michael T

“…In 2016, WHO designated Lassa fever a priority disease for epidemic preparedness as part of the WHO Blueprint for Action to Prevent Epidemics. One aspect of…”
Get full text

Influenza response planning for the centers of excellence for influenza research and surveillance: Science preparedness for enhancing global health security by Moore, Kristine A., Ostrowsky, Julia T., Mehr, Angela J., Osterholm, Michael T., Compans, Richard W, García‐Sastre, Adolfo, Orenstein, Walter A, Pekosz, Andrew, Perez, Daniel R, Rothman, Richard E, Sauer, Lauren M, Schultz‐Cherry, Stacey L, Steel, John, Topham, David J, Treanor, John J, Webby, Richard J

“…Background The Centers of Excellence for Influenza Research and Surveillance (CEIRS) network, funded by the US National Institutes of Health, has been…”
Get full text

Genetic screening, prenatal diagnosis and treatment for beta thalassemia a cost analysis by Ostrowsky, Julia T

Get full text

Genetic screening, prenatal diagnosis and treatment for beta thalassemia a cost analysis by Ostrowsky, Julia T

Get full text

Cost-benefit analysis of a thalassemia disease prevention program by Ostrowsky, J T, Lippman, A, Scriver, C R

“…We offer an economic perspective on prevention of beta-thalassemia disease by means of genetic screening and prenatal diagnosis in an established program in…”
Get full text